Structural determinants for HIV-1 integrase inhibition by beta-diketo acids

Area of Science:

• Biochemistry
• Virology
• Medicinal Chemistry

Background:

• Beta-diketo acids (DKAs) are a significant class of HIV-1 integrase inhibitors.
• DKAs demonstrate antiviral properties and inhibit viral DNA integration in vitro and in vivo.
• They specifically target the 3 -end joining step of the integration reaction.

Purpose of the Study:

• To investigate the molecular interactions between DKAs and HIV-1 integrase.
• To compare the inhibitory profiles of different DKA derivatives.
• To elucidate the binding mechanisms of DKAs to viral DNA.

Main Methods:

• In vitro inhibition assays comparing DKA derivatives (5CITEP, L-708,906, and a novel bifunctional DKA).
• Oligonucleotide-based experiments with defined modifications to study DNA-protein interactions.
• Analysis of inhibitor binding to acceptor and donor sites of HIV-1 integrase.

Main Results:

• 5CITEP inhibits 3 -processing at concentrations where L-708,906 is only active on strand transfer.
• A novel bifunctional DKA derivative exhibits superior inhibition of 3 -processing compared to 5CITEP.
• Experimental data suggest the bifunctional DKA binds to both acceptor and donor sites, while L-708,906 binds selectively to the acceptor site.

Conclusions:

• DKA derivatives exhibit differential inhibition profiles against HIV-1 integrase steps.
• A novel bifunctional DKA demonstrates enhanced efficacy by targeting multiple binding sites.
• Understanding these molecular interactions can guide the design of more potent anti-HIV-1 integrase drugs.